Article

marketwatch.com on 2020-07-30 11:57

Johnson & Johnson starts trial of COVID-19 vaccine after producing immune response in primates

Johnson & Johnson undefined said Thursday that its lead vaccine candidate protected against infection with SARS-CoV-2, the virus that causes ...

Related news